Prot# MNTX 301: A Double-Blind Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Symptomatic Constipation Due to Chronic Opioid Therapy in Patients with Advanced Medical Illness

Project: Research project

Project Details

StatusFinished
Effective start/end date4/7/044/5/07

Funding

  • Progenics Pharmaceuticals, Inc. (MNTX 301)